MedTrace Logo

Search for Biomarkers in Human Glaucoma: Lymphocytes Alterations and Rate of Progression

NCT00981422 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2009-09-22

No results posted yet for this study

Summary

The aim of this study was to evaluate the lymphocyte phenotype in primary open- angle glaucoma (POAG) patients compared to healthy subjects of the same age, in order to confirm the importance of immune responses in glaucoma and the possible correlation to the severity of the disease.

Conditions

  • Glaucoma, Open-Angle

Sponsors & Collaborators

  • University of Parma

    lead OTHER

Principal Investigators

  • Stefano A Gandolfi, MD · Ophthalmology Institute, University of Parma, Italy

Eligibility

Min Age
19 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2007-12-31
Completion
2008-06-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00981422 on ClinicalTrials.gov